SonoSite predicts lower second-half revenue
After a year that saw Bothell, WA-based SonoSite partner with ultrasound giant ATL and that saw the company’s flagship product, a handheld digital ultrasound system, purchased by the 19 member countries of NATO for battlefield use
After a year that saw Bothell, WA-based SonoSite partner with ultrasound giant ATL and that saw the companys flagship product, a handheld digital ultrasound system, purchased by the 19 member countries of NATO for battlefield use (SCAN 4/12/00), SonoSite predicted its second-half revenue will not meet analysts expectations.
SonoSite blamed the slump on a physician strike in South Korea and on a hospital market capital freeze in Taiwan. The company said in a statement, however, that U.S. sales are expected to grow.
The 5-pound portable SonoSite 180 system was developed using licensed ATL technology, and part of the SonoSite system is manufactured by ATL, a Philips Medical System company. ATL Ultrasound is able to bundle sales of the handheld SonoSite 180 with its own ultrasound systems.
SonoSite and ATL Ultrasound signed an agreement in March of this year giving ATL exclusive rights to include SonoSites SonoHeart handheld echocardiology device with sales of its own HDI ultrasound systems and with cardiac catheterization systems from Philips Medical Systems.
The SonoHeart is to be launched this month at the Japanese Society of Cardiology meeting in Osaka. The SonoHeart agreement with ATL covers distribution of products in cardiology-related segments worldwide, with the exception of Japan. Distribution in Japan is covered under an agreement with Olympus Optical.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
